As of July 2024, an Illinois man has filed a lawsuit against Novo Nordisk and Eli Lilly, alleging they failed to warn about the risks of their weight loss drugs, Ozempic and Mounjaro.
In October 2022, the plaintiff’s endocrinologist prescribed Ozempic for diabetes management. He used Ozempic until January 2023, then switched to Mounjaro for the same purpose.
On June 10, 2023, the plaintiff was hospitalized with chest discomfort that escalated to severe abdominal pain. A CT scan revealed abnormal thickening in the proximal jejunal small bowel and an internal hernia, indicating ischemia and bowel obstruction. The next day, he underwent surgery for ischemic bowel resection.
The lawsuit, filed in Illinois and set to be transferred to the MDL class action in Pennsylvania, seeks compensation for his injuries, medical expenses, pain, and suffering, which he attributes to the defendants’ negligence and deceptive practices.
There are 105 personal injury lawsuits for gastroparesis, ileus, and intestinal blockage or obstruction pending in MDL 3094 in the Eastern District of Pennsylvania.
The Judicial Panel on Multidistrict Litigation reassigned the Ozempic MDL to Judge Karen S. Marston in June following the death of Judge Gene E. K. Pratter in May 2024. Judge Pratter had been overseeing the cases and had appointed a Plaintiffs’ Committee to guide the litigation.
Earlier, in February 2024, the Judicial Panel on Multidistrict Litigation consolidated 55 lawsuits into the federal MDL, expecting the number to grow significantly. The FDA’s recent evaluations and label updates have also influenced the ongoing lawsuits, adding the Ozempic warning label about the risks of intestinal blockages and other gastrointestinal problems associated with Ozempic.
Ozempic (semaglutide) is used to manage type 2 diabetes and treat obesity. However, it has been associated with serious gastrointestinal issues. Studies and reports have linked prescribed Ozempic to conditions such as gastroparesis (stomach paralysis), causing significant digestive discomfort and complications.
Known Injuries and Side Effects
Ozempic can have a range of side effects, including:
These side effects highlight the importance of being informed about the potential risks associated with Ozempic use.
The primary factor determining eligibility revolves around the medical evidence linking Ozempic consumption to the development of specific health issues. Plaintiffs need to provide medical documentation to substantiate their claims that their health conditions are directly linked to their use of Ozempic.
Another critical aspect of eligibility is the duration and dosage of Ozempic intake. Individuals who took the drug for longer periods or at higher dosages might have a stronger case. Additionally, being unaware of the potential risks at the time of consumption is crucial, as many lawsuits claim that manufacturers failed to provide adequate warnings about the drug’s risks.
By consulting with an experienced attorney, potential plaintiffs can better understand their eligibility and the legal procedures involved in filing a claim in the Ozempic lawsuit MDL.
Filing an Ozempic lawsuit, like other personal injury or product liability claims, follows a series of steps to ensure the validity and strength of the claim. Here are the general steps to file a lawsuit:
Following these steps carefully can help ensure a robust legal case against the manufacturers of Ozempic. Working with a knowledgeable attorney will significantly increase your chances of a successful outcome, helping you secure the compensation needed for medical expenses, pain and suffering, and other related damages.
When Will Ozempic Lawsuit Be Settled? The timeline for Ozempic lawsuits to reach settlements is currently uncertain as cases are still in the early stages of litigation. The outcome of initial cases could set precedents for future settlements.
Settlements in Ozempic lawsuits may cover medical expenses, lost wages, pain and suffering, and other damages related to the adverse effects of the medication. As the litigation progresses, the resolution of early cases will provide insights into how future claims might be handled and what compensation plaintiffs might expect.
An Illinois man has filed a lawsuit against Novo Nordisk and Eli Lilly, alleging they failed to warn about the risks of their weight loss drugs, Ozempic and Mounjaro.
In October 2022, the plaintiff’s endocrinologist prescribed Ozempic for diabetes management. He used Ozempic until January 2023, then switched to Mounjaro for the same purpose.
On June 10, 2023, the plaintiff was hospitalized with chest discomfort that escalated to severe abdominal pain. A CT scan revealed abnormal thickening in the proximal jejunal small bowel and an internal hernia, indicating ischemia and bowel obstruction. The next day, he underwent surgery for ischemic bowel resection.
The lawsuit, filed in Illinois and set to be transferred to the MDL class action in Pennsylvania, seeks compensation for his injuries, medical expenses, pain, and suffering, which he attributes to the defendants’ negligence and deceptive practices.
There are 105 personal injury lawsuits for gastroparesis, ileus, and intestinal blockage or obstruction pending in MDL 3094 in the Eastern District of Pennsylvania.
Judge Gene E. K. Pratter, overseeing the MDL, passed away. This may affect the pace of litigation.
The Judicial Panel on Multidistrict Litigation consolidated 55 lawsuits into the Federal Multidistrict Litigation, expecting this number to rise significantly.
Reports indicate that Ozempic users are experiencing severe digestive issues, prompting legal actions against Novo Nordisk.
Ozempic has been linked to severe gastrointestinal issues, including gastroparesis and intestinal blockage.
Consult with your healthcare provider to discuss potential risks and consider alternative treatments if necessary.
Potential compensation may cover medical expenses, lost wages, pain and suffering, and other related damages.
The duration varies based on case specifics and legal strategies. Consulting with an attorney will provide a clearer timeline.
Our assistance makes locating a lawyer skilled in handling cases against pharmaceutical and drug companies like the Ozempic lawsuits easy. Simply complete our contact form, and upon submission, a member of our team will promptly contact you to link you with a seasoned attorney tailored to your case to assist you in the legal process.
Reach out to us today without delay to secure the expert legal support and Ozempic lawyer you need.